Breaking News
December 19, 2018 - Incorrect prescribing warnings in electronic prescribing systems
December 19, 2018 - New $1.6 million NIH grant supports study on a gene vital to circadian rhythms
December 19, 2018 - Racial Disparities Seen Among Teens Undergoing Flu Vaccination
December 19, 2018 - To resolve inflammation, location matters
December 19, 2018 - Research identifies new therapeutic target for cancer treatment and tissue regeneration
December 19, 2018 - Energy costs, social isolation contribute to health risk of older adults in extreme weather
December 19, 2018 - Potential combination therapy against rare disease of the bone marrow could improve treatment
December 19, 2018 - Researchers aim to improve cognition, reverse weight gain in schizophrenia
December 19, 2018 - UC San Diego Health offers new DRG stimulation device for phantom limb pain
December 19, 2018 - Study examines relationship between growth restriction and risk of childhood mortality
December 19, 2018 - New study provides insights on increased risk of suicide in young patients visiting ED
December 19, 2018 - AHA: Thyroid Problems Linked to Worsening Heart Failure
December 19, 2018 - World-first coeliac disease vaccine enters Phase 2 trials
December 19, 2018 - RNA sequencing offers novel insights into the microbiome
December 19, 2018 - A promising, effective vaccine for common respiratory disease
December 19, 2018 - Protein may slow progression of emphysema, study finds
December 19, 2018 - Studying atrial fibrillation — and exploring new frontiers in precision health
December 19, 2018 - A New Way To Get College Students Through A Psychiatric Crisis — And Back To School
December 19, 2018 - Optum, UnitedHealthcare take action to help people affected by North Carolina winter storms
December 18, 2018 - Weight change in middle-aged, elderly Chinese Singaporeans related to increased risk of death
December 18, 2018 - Immune cells sacrifice themselves to protect us from invading bacteria
December 18, 2018 - Watching brain cells fire, with a twist of gravitational waves
December 18, 2018 - 2018 in Review
December 18, 2018 - Getting the Most Out of the CLARITY Technique
December 18, 2018 - NVF shoes provide a viable option for track and road racing
December 18, 2018 - CRISPR may restore effectiveness of chemotherapies used to treat lung cancer
December 18, 2018 - New app accurately measures and charts progression of skin wounds
December 18, 2018 - Persistent Discrimination ID’d Among Physician Mothers
December 18, 2018 - Cellphone technology developed to detect HIV
December 18, 2018 - A Stanford doctor hits the field with the 49ers — as their airway management physician
December 18, 2018 - The Rise of Anxiety Baking
December 18, 2018 - Just one night of sleep deprivation increases the urge to eat
December 18, 2018 - Study reveals mechanism behind failed remyelination in MS
December 18, 2018 - New genetic testing method increases the precision of biomarker analysis
December 18, 2018 - Simple technique to effectively treat underdiagnosed cause of debilitating chest pain
December 18, 2018 - Barbershop-based medical intervention can successfully lower blood pressure, new data shows
December 18, 2018 - Food labels have caused changes in consumers’ intake and industry’s use of key additives
December 18, 2018 - Sickest children could benefit from split liver transplants
December 18, 2018 - Scientists create patient-specific model to identify most effective treatment for appendix cancer
December 18, 2018 - ‘Little Foot’ endocast reveals a small brain combining ape-like and human-like features
December 18, 2018 - New therapy for childhood blindness shows ‘very promising’ results
December 18, 2018 - Researchers discover promising new compound against Buruli ulcer
December 18, 2018 - Study finds significant use of traditional, complementary and alternative medicines in Sub-Saharan Africa
December 18, 2018 - California Farm Implicated in Outbreak of E. coli Tied to Romaine Lettuce
December 18, 2018 - Mobile health has power to transform HIV/AIDS nursing
December 18, 2018 - Celiac Vaccine in Clinical Trials at Columbia
December 18, 2018 - Research into mental health first aid prompts practical guidance and resources for workplace
December 18, 2018 - Researcher conducts study to investigate peripheral blood markers of Alzheimer’s disease
December 18, 2018 - Researchers identify link between mucus in the small airways and pulmonary fibrosis
December 18, 2018 - EU Commission’s Health Policy Platform to host EKHA program on transplantation
December 18, 2018 - Survivors of childhood Hodgkin lymphoma have high risk of developing solid tumors
December 18, 2018 - Small changes to cafeteria design can get kids to eat healthier, new assessment tool finds
December 18, 2018 - From Machines to Cyclic Compounds
December 18, 2018 - New study reveals best assessment tools to establish delirium severity
December 18, 2018 - Rice University scientists develop synthetic protein switches to control electron flow
December 18, 2018 - Home-based pulmonary function monitoring for teens with Duchenne muscular dystrophy
December 18, 2018 - Researchers identify potential target for new breast cancer treatments
December 18, 2018 - National Biofilms Innovation Centre award grant to Neem Biotech for novel anti-biofilm drug development
December 18, 2018 - Artificial intelligence and the future of medicine
December 18, 2018 - Montana State doctoral student receives grant for her work to improve neuroscience tool
December 18, 2018 - Early postpartum initiation of opioids associated with persistent use
December 18, 2018 - Russian scientists identify molecular ‘switch’ that could be target for treatment of allergic asthma
December 18, 2018 - Surgeons make more mistakes in the operating room during stressful moments, shows study
December 18, 2018 - Immune cells explode themselves to inform about the danger of invading bacteria
December 18, 2018 - Malnutrition in children with Crohn’s disease linked with increased risk of surgical complications
December 18, 2018 - FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)
December 18, 2018 - The long and short of CDK12
December 18, 2018 - Hologic’s Cynosure division introduces TempSure Surgical RF technology in North America
December 18, 2018 - CMR Surgical partners with Nicholson Center to launch U.S.-based training program for Versius
December 18, 2018 - Findings reinforce guidelines for cautious use of antipsychotics in younger populations
December 18, 2018 - Study finds new strains of hepatitis C virus in sub-Saharan Africa
December 18, 2018 - New battery-free, implantable device aids weight loss
December 18, 2018 - Parental alcohol use disorder associated with offspring marital outcomes
December 18, 2018 - Novel Breast Imaging Technique Might Cut Unnecessary Biopsies
December 18, 2018 - What can a snowflake teach us about how cancer spreads in the body?
December 18, 2018 - Management of nausea and vomiting in pregnancy costs the NHS more than previously thought
December 18, 2018 - Green leafy vegetables may reduce risk of developing liver steatosis
December 18, 2018 - Veganism linked to nutrient deficiencies and malnutrition if not planned correctly
December 18, 2018 - Coming Soon: A Tiny Robot You Swallow to Help You Stay Healthy
December 18, 2018 - Modified malaria drug proven effective at inhibiting Ebola
Study: Insufficient Oversight on Modifying FDA-Approved Devices

Study: Insufficient Oversight on Modifying FDA-Approved Devices

image_pdfDownload PDFimage_print

Action Points

  • Manufacturers of dermatologic devices are increasingly gaining approval for device modifications via post-initial approval pathways requiring minimal supporting clinical data, which could influence device effectiveness and safety.
  • Note that these data suggest that greater transparency and higher standards of review may improve inconsistencies in usage of pathways for device approvals, and this will allow better assessment of the safety of device modifications.

Dermatologic device makers often slip substantial product changes through FDA clearance by taking advantage of loose premarket approval (PMA) supplement applications, researchers said.

A search through the FDA online PMA database showed that for the 27 Class III dermatologic devices approved between 1980 and 2016 through the PMA pathway, 562 PMA supplements were green-lighted. On the whole, device makers ramped up their use of these supplemental applications over time: in 1980-1989, supplements were approved at 3.7 per year, whereas the 2006-2015 period saw 36.7 supplements approved per year (an 891.9% increase), according to the study published online in JAMA Dermatology.

“This indicates a higher rate of supplements per device-year in dermatology than other reported specialties, including orthopedics, otolaryngology, and cardiology,” said investigators led by Harib Ezaldein, MD, of University Hospitals Cleveland Medical Center. The 27 dermatologic devices that had approved changes were 14 injectables, 11 photodynamic therapies, one dermal replacement matrix, and one diagnostic imaging instrument.

The worry is that dermatology device changes may not be sufficiently backed by clinical data in many cases, the team suggested, noting that the 30-day supplement track that does not require clinical data (meant only for adjustments to a device’s manufacturing process) accounted for 42.5% of supplemental PMA approvals.

Meanwhile, it appeared that the rigorous panel-track pathway was much less popular, coming in at just 2.8% of PMA supplement approvals. This track requires clinical data and is intended for significant changes such as those in device design or performance, or a new indication for use.

It is therefore problematic that another track, the 180-day process, was used for 41.7% of label indication changes instead of the aforementioned comprehensive panel track requiring clinical data and a formal review process. “As manufacturers make increasing use of supplemental applications, minor device changes may occur without supporting clinical data, which could pose a safety risk to patients,” Ezaldein and colleagues wrote.

Indeed, safety issues came up eventually in many cases, with 14.8% of dermatologic devices undergoing low-risk recalls (Class II or III) and 37.0% voluntarily withdrawn by the manufacturer. For example, both injectable products from Merz were recalled after undergoing 135- and 30-day applications).

“The current regulatory environment does not provide sufficient information necessary for dermatologists to make informed clinical judgment regarding potential device problems,” the researchers emphasized. “There is a dearth of FDA review memos in dermatology, which are normally published to disclose information about modifications. Increasing disclosure about device modifications across all supplementary pathways may promote more reliable safety in Class III dermatologic devices.”

Caveats to the study include the exclusion of devices approved through the cheaper and less robust 510(k) pathway, the authors acknowledged.

Nonetheless, they suggested that to make devices safer for patients, an advisory board tasked with reviewing a product for clinically significant device drift after a defined number of years or PMA supplement applications should be created.

Employees of the FDA responded in an accompanying editorial that the agency is in fact making efforts to improve how it assesses medical device safety: In building the National Evaluation System for Health Technology (NEST), it “will link and synthesize data from different sources across the medical device landscape, including clinical registries, electronic health records, and medical billing claims,” wrote Laura Marquart, MD, and colleagues from the FDA Center for Devices and Radiological Health in Silver Spring, MD.

“The FDA anticipates exponential growth in knowledge about actual clinical use of specific devices through NEST, which will more efficiently generate evidence for, and decrease the time and cost of, medical device evaluation,” the editorial continued. “Concurrently, the FDA is seeking ways to enhance the robustness of available clinical evidence through the development and coordination of registries.”

Both Ezaldein and co-authors and Marquart and co-authors reported having no relevant conflicts of interest.

2018-01-25T13:00:00-0500

Tagged with:

About author

Related Articles